博士,副教授
邮箱地址:zhao_lj@jlu.edu.cn
教育经历
2006/09–2010/06,4556银河国际在线,病理学与病理生理学,博士
2003/09–2006/06,4556银河国际在线,药理学,硕士
1992/09–1997/06,白求恩医科大学,临床医学,学士
工作经历
2016/06–至今,4556银河国际在线,4556银河国际在线,副教授
2016/12–2018/01,美国乔治亚医学院,访问学者
2014/09–2016/06,4556银河国际在线,基础医学院,副教授
2010/09–2014/08,4556银河国际在线,基础医学院,讲师
1997/09–2003/06,白求恩医科大学/4556银河国际在线,校报编辑部,编辑
研究方向
肿瘤康复
放射损伤康复
近五年主持或参加科研项目及人才计划项目情况
1. 雄激素合成关键酶AKR1C3:小檗碱防治去势抵抗性前列腺癌的新靶标,国家自然科学基金青年基金,81302206,2014.01-2016.12,23万元,完成,负责人
2. 多靶点干预:CUDC-907协同ABT-199抑制AML的分子机制,基金委面上项目,31671438,2017.01-2018.12,30万元,运行,第1参加人
3. Bcl-2选择性抑制剂ABT-199抗急性髓细胞白血病的机制研究,基金委面上项目,31471295,2015.01-2018.12,85 万元,运行,第3参加人
4. 靶向AKR1C3多功能纳米复合粒子治疗去势抵抗性前列腺癌的研究,省科技厅基础处,20160101237JC,2016.01-2018.12,10万元,运行,负责人
5. 多功能三嵌段纳米AKR1C3 siRNA复合体治疗激素抵抗性前列腺癌的研究与开发,省计委,2013.01-2014.12,15 万元,完成,负责人
6. RBM5/RBM10-TNF-ɑ信号转导通路在肺癌发生中作用机制的研究,省科技厅基础处,20150101151JC,2015.01-2017.12,10 万元,运行,第1参加人
7. 人参皂苷单体抗喉癌与放疗增敏作用及药效学研究,省科技厅医药办,20150204003YY,20150204006YY,2015.01-2017.12,22万元,运行,第3参加人
8. 新型雌激素受体蛋白ERβX药用价值研制与开发,省科技厅医药办,20150204031YY,2015.01-2017.12,15万元,运行,第3参加人
9. 重组分子靶向R9-GRIM-19融合蛋白抗消化道恶性肿瘤新药临床前研究,省科技厅医药办,20150204006YY,2015.01-2017.12,22万元,运行,第5参加人
10. 阿片依赖康复新药——嘌呤核苷酸口服药物的研究,省科技厅医药办,20140311066YY,2014.01-2016.12,60万元,运行,第1参加人
11. 五味子有效成分逆转卵巢癌化疗耐药作用及分子机制研究,省科技厅医药办,20140203013YY,2014.01-2016.12,40万元,验收,第1参加人
12. 纳米PPD叶酸复合体抗肿瘤作用及机制研究,省科技厅国际合作处,20140413044GH,2014.01-2016.12,10万元,运行,第2参加人
13. 新型硒类化合物对晚期前列腺癌的治疗作用及其分子机制的研究,基金委面上项目,81272851,2013.01-2016.12,76 万元,完成,第3参加人
14. 注射用基因工程GRIM-19蛋白抗肿瘤制剂的临床前研究,吉林省发改委,2014G073,2014.01-2017.12,11.5 万元,运行,第1参加人
15. 吉林省纳米医学工程实验室建设,吉林省发改委,2014N146,2014.01-2016.12,50 万元,运行,第6参加人
16. 除草剂阿特拉津对卵巢癌stats3信号传导通路的影响,吉林省财政厅,2015.03-2018.03,10 万元,运行,第1参加人
17. 利用基因编辑系统0.00RISPR-0.005.00s9靶向HMG3.001治疗去势抵抗性前列腺癌的研究,吉林省教育厅,JJKH20170831KJ,2017.01-2018.12,5万元,运行,第1参加人
18. ERβ阻断胆固醇从头合成雄激素途径抑制CRPC发生的机制研究,省卫生厅,2015.01-2017.12,3 万元, 运行,第1参加人
近五年以第一作者或通讯作者发表的SCI论文
[1] Changwen Ning#, Min Liang, Shuang Liu, Guan Wang, Holly Edwards, Yang Xia, Lisa Polin, Gregory Dyson, Jeffrey W. Taub, Ramzi M. Mohammad, Asfar S. Azmi,Lijing Zhao*,Yubin Ge*. Targeting ERK enhances the cytotoxic effect of the novel PI3K and mTOR dual inhibitor VS-5584 in preclinical models of pancreatic cancer. Oncotarget, 2017.7.4, 8(27):44295-44311
[2] Bo Teng#*,Lijing Zhao#, Jing Gao#, Peng He, Junyu Chen, Qingqie Feng, Chunhui Yi. 20(s)-protopanaxadiol (PPD) increases the radiotherapy sensitivity of laryngeal carcinoma. Food Funct, 2017.12.13, 8(12):4469-4477
[3] Hu Kebang, Tian Yong, Du Yanwei, Huang Liandi, Chen Juyu, Li Na, Liu Wei, Liang Zuowei*, Zhao Lijing*. Atrazine promotes RM1 prostate cancer cell proliferation by activating STAT3 signaling. Int J Oncol, 48(5):2166-74, 2016
[4] Tian Yuantong#, Zhao Lijing#, Wang Ye, Zhang Haitao, Xu Duo, Zhao Xuejian, Li Yi, Li Jing*. Berberine inhibits androgen synthesis by interaction with aldo-keto reductase 1C3 in 22Rv1 prostate cancer cells.Asian J Androl. 18(4):607-612, 2016
[5] Teng Bo, He Peng, Huang Liandi, Liang Yuan, Wang Yafang, Zhang Xuelei*, Zhao Lijing*. Overview of relation between air pollution and allergic rhinitis.Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi.50(8):683-5, 2015
[6] Guan Wang, Xiaojia Niu, Wenbo Zhang, Timothy Caldwell, Holly Edwards, Wei Chen, Jeffrey W. Taub,Lijing Zhao*, Yubin Ge*. Synergistic antitumor interactions between MK-1775 and panobinostat in preclinical models of pancreatic cancer. Cancer Letters, 2014
[7] Dexia Kong#,Lijing Zhao#, Yanwei Du, Ping He, Yabin Zou, Luoluo Yang, Liankun Sun, Hebin Wang, Deqi Xu, Xiangwei Meng*, Xun Sun*. Overexpression of GRIM-19, a mitochondrial respiratory chain complex I protein, suppresses hepatocellular carcinoma growth. Int J Clin Exp Pathol, 7(11):7497-7507, 2014
[8] Wei Liu, Yanwei Du, Jian Liu, Hebin Wang, Daguang Sun, Dongmei Liang,Lijing Zhao*, Jincheng Shang*. Effects of atrazine on the oxidative damage of kidney in Wister rats. Int J Clin Exp Med, 7(10):3235-3243, 2014
[9] Yanwei Du#, Yan Meng#, Xuejiao Lv#, Lirong Guo, Xiaoqin Wang, Zhenzhong Su, Lu Li, Na Li, Shuhua Zhao*,Lijing Zhao*, Xuejian Zhao. Dexamethasone attenuates LPS-induced changes in expression of urea transporter and aquaporin proteins, ameliorating brain endotoxemia in mice. Int J Clin Exp Pathol, 7(12), 2014
[10] Bo Cao, Yanfeng Qi, Yan Yang, Xichun Liu, Duo Xu, Wei Guo, Yang Zhan, Zhenggang Xiong, Allen Zhang, Alun R. Wang, Xueqi Fu, Haitao Zhang,Lijing Zhao*, Jingkai Gu*, Yan Dong*. 20(s)- Protopanaxadiol inhibition of progression and growth of castration-resistant prostate cancer. Plos one, 9(11): e111201, 2014
[11] Shaohua Chen#, Guan Wang#, Xiaojia Niu, Jianyun Zhao, Wenxi Tan, Hebin Wang,Lijing Zhao*, Yubin Ge*. Combination of Azd2281 (Olaparib) and Gx15-070 (Obatoclax) results in synergistic antitumor activities in preclinical models of pancreatic cancer. Cancer Lett. 2014 Feb 15. pii: S0304-3835(14)00101-3.
[12] Na Li#,Lijing Zhao#, Zhe Lin, Jing Li, Hui Li, Jiaming Sun, Kai Zhu, Zhixin Yu , Kejin Xu, Qing Yang, Xiaobo Qu. Metabonomics study of the anti-osteoporosis effect of velvet collagen hydrolysate using rapid resolution liquid chromatography combined with quadrupole time-of -flight tandem mass spectrometry. Journal of Liquid Chromatography & Related Technologies.
[13] Yuantong Tian#,Lijing Zhao#, Haitao Zhang, Xichun Liu, Lijuan Zhao, Xuejian Zhao, Yi Li*, Jing Li*. AKR1C3 overexpression may serve as a promising biomarker for prostate. Diagn Pathol, 2014, 99(1):42, 2014
[14] Lijing Zhao, Lianji Wen, Qingjie Feng, Hebin Wang, Na Li, Yafang Wang, Zuowen Liang, Bo Teng*. mTOR inhibitor AZD8055 inhibits proliferation and induces apoptosis in laryngeal carcinoma. Int J Clin Exp Med, 7(2): 337-347, 2014
[15] Shuhua Zhao, Jian Liu, Fan Zhao, Wei Liu, Na Li, Qi Suo, Jing Zhao,Lijing Zhao*.Sub-acute exposure to the herbicide atrazine suppresses cell immune functions in adolescent mice. BioScience Trends. 7(4):193-201, 2013
参加社会组织
吉林康复学会健康管理委员会常务委员
中国药理学会肾脏药理专业委员会委员
中国老年学和老年医学学会老年病分会干细胞专家委员会委员
吉林省药理学会 会员